Approved for MENVEO is a vaccine indicated for active immunization to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y, and W-135 in individuals 2 months through 55 years of age. MENVEO does not prevent N. meningitidis serogroup B infections.. Neisseria meningitidis is a gram-negative diplococcus that causes life-threatening invasive disease such as…
Loading full data from Know Your Drugs Institute…